Andreas Limacher

5PUBLICATIONS
38CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersCommunication technology and digital media studiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 08, 2025
Dapagliflozin's impact on hormonal regulation and ketogenesis in type 1 diabetes: a randomised controlled crossover trial.

Andreas Gübeli, Nicole Steiner, Andreas Limacher

|Jun 04, 2025
Effect of metformin on hypoxia-associated gene expression in oral cavity squamous cell carcinoma in non-diabetic patients - a prospective window of opportunity study.

Simon A Mueller, Olgun Elicin, Bastien Monney

|Apr 29, 2024
Acceptance, Satisfaction, and Preference With Telemedicine During the COVID-19 Pandemic in 2021-2022: Survey Among Patients With Chronic Pain.

Michael Alexander Harnik, Alina Scheidegger, Larissa Blättler

|Feb 04, 2022
Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients.

Simeon Schietzel, Manuel Anderegg, Andreas Limacher

|Nov 10, 2020
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.

Delphine Sculier, Gilles Wandeler, Sabine Yerly

Pageof 1

Frequent Collaborators

1 joint publications

Delphine Sculier

1 joint publications

Sabine Yerly

1 joint publications

Annalisa Marinosci

1 joint publications

Marcel Stoeckle